Q: What is Tecartus used for?

Tecartus is used to treat B-cell acute lymphoblastic leukemia and mantle cell lymphoma .

Q: How does Tecartus work?

The CAR T-Cell Process Tecartus is a personalized treatment made from your own white blood cells, specifically T cells. These cells are a vital part of the immune system that normally help the body fight infections and other diseases. The process of how Tecartus works involves several steps: Collection: Your T cells are collected from your blood through a process called leukapheresis. Modification: In a laboratory, these cells are genetically changed to include a special protein called a chimeric antigen receptor (CAR). Targeting: This new receptor acts like a GPS, allowing the T cells to recognize and attach to a specific protein called CD19, which is found on the surface of certain cancerous B cells. Elimination: Once the modified cells are infused back into your body, they multiply and seek out the cancer cells. When they bind to the CD19 protein, the T cells are activated to kill the cancer cells. By reprogramming your own immune system, Tecartus helps the body identify and attack cancer cells that it might otherwise ignore.

Q: What are the active ingredients in Tecartus?

The active ingredient in Tecartus is brexucabtagene autoleucel .

Q: What are the side effects of Tecartus?

Common side effects of Tecartus may include: fever fatigue nausea and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Tecartus?

Tecartus belongs to the CAR T-cell therapy drug class.

Q: What is the dosage of Tecartus and how do I take it?

Administration Process Tecartus is a personalized therapy created from your own immune cells. The process begins with a procedure to collect white blood cells from your blood. These cells are modified in a laboratory and then returned to your body. Before the infusion, you will receive chemotherapy for a few days to prepare your immune system. On the day of treatment, your healthcare provider may give you other medications, such as an antihistamine and a fever reducer, to help prevent reactions during the infusion. How the Treatment is Given The medication is given as a single dose through an intravenous (IV) catheter. The infusion is performed by healthcare professionals at a certified treatment center equipped to monitor and manage potential side effects. Follow-Up Care After receiving the infusion, you will need to stay near the treatment facility for several weeks. This allows your medical team to monitor your recovery and respond quickly if you experience any complications. Your healthcare provider will determine the exact length of time you need to remain under close observation.

Q: Is Tecartus safe during pregnancy and breastfeeding?

Pregnancy There is no clinical data regarding the use of Tecartus in pregnant women. It is not known whether the medication can cause fetal harm or affect a person's ability to have children. Because this is a cellular therapy, there is a theoretical risk that the modified cells could cross the placenta and affect the developing fetus. Before starting treatment, healthcare providers usually require a pregnancy test for individuals who can become pregnant. It is important to use effective birth control to prevent pregnancy during and after the treatment process. If you are pregnant or planning to become pregnant, you should consult with your doctor about the potential risks. Breastfeeding It is unknown if Tecartus is present in human breast milk or if it has any effect on a breastfed child or milk production. Due to the lack of data, the safety of breastfeeding during treatment has not been established. Patients should talk to their healthcare provider to evaluate the risks and benefits of breastfeeding while receiving this therapy.

Q: What forms and strengths does Tecartus come in?

Available Forms Tecartus is provided as a suspension for intravenous infusion. This medication is an autologous cell-based gene therapy, which means it is manufactured using a patient's own white blood cells. The medication is supplied in the following format: Suspension for infusion Infusion bag Each treatment is custom-made for the individual patient and is delivered as a cryopreserved suspension intended for intravenous administration.

Q: What is the FDA approval status of Tecartus?

FDA Approval Status Tecartus (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. It is FDA-approved for the treatment of adult patients with: Relapsed or refractory mantle cell lymphoma (MCL). Relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Relapsed means the cancer has returned after a period of improvement, while refractory means the cancer did not respond to previous treatments. Boxed Warning The FDA has issued a Boxed Warning for Tecartus, which is the most serious warning required for a medication. This warning highlights the risk of: Cytokine Release Syndrome (CRS): A severe and potentially life-threatening systemic inflammatory response. Neurological Toxicities: Serious or life-threatening neurological reactions, such as confusion, seizures, or loss of consciousness. REMS Program Because of the risks of CRS and neurological toxicities, the FDA requires Tecartus to be administered through a restricted program called the Tecartus Risk Evaluation and Mitigation Strategy (REMS). This program ensures that the therapy is only available at certified healthcare facilities that are specially trained to monitor patients and manage severe adverse reactions.

Question 1

What is Tecartus?

Accepted Answer

Tecartus is a type of immunotherapy called chimeric antigen receptor (CAR) T-cell therapy. It is a personalized treatment created using a patient's own immune system cells, which are modified in a laboratory to help them identify and attack cancer cells.

These modified cells are designed to target a specific protein called CD19 found on the surface of certain cancer cells. Once active, these cells function as a living treatment to help the immune system fight the disease.

Question 2

What is Tecartus used for?

Accepted Answer

Tecartus is used to treat B-cell acute lymphoblastic leukemia and mantle cell lymphoma.

Question 3

How does Tecartus work?

Accepted Answer

The CAR T-Cell Process

Tecartus is a personalized treatment made from your own white blood cells, specifically T cells. These cells are a vital part of the immune system that normally help the body fight infections and other diseases.

The process of how Tecartus works involves several steps:

Collection: Your T cells are collected from your blood through a process called leukapheresis.
Modification: In a laboratory, these cells are genetically changed to include a special protein called a chimeric antigen receptor (CAR).
Targeting: This new receptor acts like a GPS, allowing the T cells to recognize and attach to a specific protein called CD19, which is found on the surface of certain cancerous B cells.
Elimination: Once the modified cells are infused back into your body, they multiply and seek out the cancer cells. When they bind to the CD19 protein, the T cells are activated to kill the cancer cells.

By reprogramming your own immune system, Tecartus helps the body identify and attack cancer cells that it might otherwise ignore.

Question 4

What are the active ingredients in Tecartus?

Accepted Answer

The active ingredient in Tecartus is brexucabtagene autoleucel.

Question 5

What are the side effects of Tecartus?

Accepted Answer

Common side effects of Tecartus may include:

fever
fatigue
nausea
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Tecartus?

Accepted Answer

Tecartus belongs to the CAR T-cell therapy drug class.

Question 7

What is the dosage of Tecartus and how do I take it?

Accepted Answer

Administration Process

Tecartus is a personalized therapy created from your own immune cells. The process begins with a procedure to collect white blood cells from your blood. These cells are modified in a laboratory and then returned to your body.

Before the infusion, you will receive chemotherapy for a few days to prepare your immune system. On the day of treatment, your healthcare provider may give you other medications, such as an antihistamine and a fever reducer, to help prevent reactions during the infusion.

How the Treatment is Given

The medication is given as a single dose through an intravenous (IV) catheter. The infusion is performed by healthcare professionals at a certified treatment center equipped to monitor and manage potential side effects.

Follow-Up Care

After receiving the infusion, you will need to stay near the treatment facility for several weeks. This allows your medical team to monitor your recovery and respond quickly if you experience any complications. Your healthcare provider will determine the exact length of time you need to remain under close observation.

Question 8

Is Tecartus safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is no clinical data regarding the use of Tecartus in pregnant women. It is not known whether the medication can cause fetal harm or affect a person's ability to have children. Because this is a cellular therapy, there is a theoretical risk that the modified cells could cross the placenta and affect the developing fetus.

Before starting treatment, healthcare providers usually require a pregnancy test for individuals who can become pregnant. It is important to use effective birth control to prevent pregnancy during and after the treatment process. If you are pregnant or planning to become pregnant, you should consult with your doctor about the potential risks.

Breastfeeding

It is unknown if Tecartus is present in human breast milk or if it has any effect on a breastfed child or milk production. Due to the lack of data, the safety of breastfeeding during treatment has not been established. Patients should talk to their healthcare provider to evaluate the risks and benefits of breastfeeding while receiving this therapy.

Question 9

What forms and strengths does Tecartus come in?

Accepted Answer

Available Forms

Tecartus is provided as a suspension for intravenous infusion. This medication is an autologous cell-based gene therapy, which means it is manufactured using a patient's own white blood cells.

The medication is supplied in the following format:

Suspension for infusion
Infusion bag

Each treatment is custom-made for the individual patient and is delivered as a cryopreserved suspension intended for intravenous administration.

Question 10

What is the FDA approval status of Tecartus?

Accepted Answer

FDA Approval Status

Tecartus (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. It is FDA-approved for the treatment of adult patients with:

Relapsed or refractory mantle cell lymphoma (MCL).
Relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Relapsed means the cancer has returned after a period of improvement, while refractory means the cancer did not respond to previous treatments.

Boxed Warning

The FDA has issued a Boxed Warning for Tecartus, which is the most serious warning required for a medication. This warning highlights the risk of:

Cytokine Release Syndrome (CRS): A severe and potentially life-threatening systemic inflammatory response.
Neurological Toxicities: Serious or life-threatening neurological reactions, such as confusion, seizures, or loss of consciousness.

REMS Program

Because of the risks of CRS and neurological toxicities, the FDA requires Tecartus to be administered through a restricted program called the Tecartus Risk Evaluation and Mitigation Strategy (REMS). This program ensures that the therapy is only available at certified healthcare facilities that are specially trained to monitor patients and manage severe adverse reactions.

Question 11

What should I know about Tecartus and cost?

Accepted Answer

Factors Influencing Cost

Tecartus is a specialized treatment created individually for each patient. Because of the complex process of collecting, modifying, and re-infusing a patient's own T-cells, the price of the medication itself is significant. Other factors that contribute to the total cost include:

Hospitalization and facility fees for the infusion and recovery period.
Pre-treatment procedures, such as lymphodepleting chemotherapy.
Long-term monitoring for potential side effects.
Travel and lodging expenses, as the treatment is only available at authorized specialized centers.

Insurance and Financial Support

Most private insurance plans and government programs like Medicare and Medicaid cover Tecartus when it is deemed medically necessary. However, insurance companies often require prior authorization before approving the treatment.

The manufacturer may offer support programs to help patients navigate the insurance process or provide financial assistance for those who qualify. Patients are encouraged to speak with their healthcare team or a financial counselor at the treatment center to explore available options.

Tecartus

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Tecartus

Hospitals.net Disclosure